.AstraZeneca has shared a very early check out the performance of its internal antibody-drug conjuga...
.After introducing a phase 3 launch based on positive midstage outcomes, iTeos and also GSK are ulti...
.The FDA needs to be extra available and also joint to discharge a surge in commendations of uncommo...
.It's an unusually busy Friday for biotech IPOs, along with Zenas BioPharma, MBX and also Bicara The...
.Atea Pharmaceuticals' antiviral has actually neglected yet another COVID-19 test, yet the biotech s...
.Neurocrine Biosciences' schizophrenia program pivot has fallen short. The biotech was actually not ...
.Sanofi has made a late access to the radioligand gathering, spending 100 million euros ($ 110 thous...
.After F2G's 1st attempt to acquire a new course of antifungal to market was derailed by the FDA, th...
.Moderna has actually sworn to reduce R&D spending through $1.1 billion through 2027. The choice ...
.Simply 4 months after Sanofi wager $80 thousand in beforehand cash on Fulcrum Therapeutics' losmapi...